Certolizumab pegol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Certolizumab pegol and local guidelines before prescribing.
Biologic (anti-TNF)
Mechanism
PEGylated anti-TNF Fab fragment.
Uses
Rheumatoid arthritis, Crohn disease, psoriasis, axial spondyloarthritis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Infections, injection-site reactions, TB reactivation.
Interactions
Live vaccines contraindicated.
Contraindications and cautions
Active infection, moderate to severe heart failure
Monitoring
TB screen, infection
Pregnancy and breastfeeding
Used in pregnancy where needed
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Minimal placental transfer, so used in pregnancy when needed.
More from the textbook: uses, cautions and other points
- Drugs - infliximab (IV - chimeric), adalimumab , etanercept (receptor fusion - not effective in IBD), certolizumab pegol (minimal placental transfer), golimumab.
Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology